“Bringing together this exceptional group of US and international experts reflects our conviction that prevention must sit at the heart of periodontal care. With more than four in ten American adults affected by periodontitis, translating rigorous science into practical, personalised guidance for the dental team has never been more important. Through Principles for Oral Health, LISTERINE and SEPA are proud to put science at the service of oral health professionals, and, ultimately, of their patients,” commented Smruti Nair, manager of medical affairs for oral care at Kenvue, the global consumer health company behind LISTERINE. Kenvue hosted the meeting at its headquarters in New Jersey.
The burden of periodontal disease in the US
The need to move towards risk-based preventive strategies is especially relevant given the high prevalence of periodontal disease in the US. According to data from the National Health and Nutrition Examination Survey (2009–2014), 42.2% of dentate US adults aged 30 or older had some degree of periodontitis, including 7.8% with severe periodontitis.1 The same study reported an overall prevalence of 59.8% among adults aged 65 or older and 59.9% among those who reported having diabetes. Prevalence was also higher among men (50.2%) than women (34.6%) and among current smokers (62.4%) than non-smokers (34.4%).
Gingivitis management and periodontal disease prevention
Effective management of gingivitis, a reversible inflammatory condition affecting the gingiva, is an important component of primary prevention of periodontitis.2–4 Patient-performed oral hygiene, including toothbrushing and interdental cleaning, remains the cornerstone of gingivitis management and periodontal disease prevention. However, with appropriate oral hygiene instructions and sufficient brushing time, mechanical biofilm removal may be insufficient for some patients.
Evidence for adjunctive antiseptics
The scientific evidence supports the use of certain antiseptic agents and mouthrinses as adjuncts to mechanical oral hygiene. Among the agents reviewed, essential oils, chlorhexidine and cetylpyridinium chloride have demonstrated efficacy in reducing dental biofilm and gingival inflammation when used alongside mechanical biofilm control.3, 5
These products should not be routinely recommended to all patients. Instead, their use should be individualised according to clinical needs, patient characteristics and difficulties achieving adequate mechanical biofilm control. However, there is insufficient direct evidence to conclude that home use of antiseptics can prevent the onset of periodontitis.3–5
Individualising periodontal prevention
Periodontal prevention should be tailored to each patient’s clinical profile and needs, taking into account factors that may make daily biofilm control more difficult.2, 6 Individualised care is particularly important for patients who have undergone periodontitis treatment and are receiving supportive periodontal care. Available evidence suggests that certain antiseptics may provide additional benefits in controlling gingival inflammation and biofilm when used alongside mechanical measures, particularly in patients with factors that make biofilm control more difficult.6 Such strategies form part of secondary prevention, which aims to prevent disease recurrence or progression and maintain treatment outcomes over the long term.
To post a reply please login or register